Camegliptin, formerly known as RG-1579 and RO4876904, is a dipeptidyl peptidase IV (DPP-4) inhibitor potentially for the treatment of type 2 diabetes. References: Kuhlmann O, Carlile D, Noe J, Bentley D. Interaction potential of Carmegliptin with P-glycoprotein (Pgp) transporter in healthy volunteers. J Drug Assess. 2014 Mar 3;3(1):28-37. doi: 10.3109/21556660.2014.900065. PubMed PMID: 27536451; PubMed Central PMCID: PMC4937633.

纯度：≥98%

CAS：813452-18-5